Zzi G, Consensus Study Group: Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J Am Soc Nephrol 2009, 20:940-949. 126. Michon B, Moghrabi A, Winikoff R, Barrette S, Bernstein ML, Champagne J, David M, Duval M, Hume HA, Robitaille N, B isle A, Champagne MA: Complications of apheresis in children. Transfusion 2007, 47:1837-1842. 127. Witt V, Stegmayr B, Ptak J, Wikstr B, Berlin G, Axelsson CG, Griskevicius A, Centoni PE, Liumbruno GM, Molfettini P, Audzijoniene J, Mokvist K, Sojka BN, Norda R, Ramlow W, Blaha M, Evergren M, Tomaz J: World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry. Transfus Apher Sci 2008, 39:255-260. 128. Bresin E, Daina E, Noris M, Castelletti F, Stefanov R, Hill P, Goodship HT, Remuzzi G: Outcome of renal transplantation in patients with Non-ShigaToxin associated hemolytic syndrome: prognostic significance of genetic background. Clin J Am Soc Nephrol 2006, 1:88-99. 129. Loirat PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/23410069 C, Fremeaux-Bacchi V: Hemolytic uremic syndrome recurrence after renal transplantation. Pediatr Transpl 2008, 12:619-629. 130. Noris M, Remuzzi G: Thrombotic microangiopathy after kidney transplantation. Am J Transplant 2010, 10:1517-1523. 131. Zuber J, Le Quintrec M, Sberro-Soussan R, Loirat C, Fr eaux-Bacchi V, Legendre C: New insights into postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol 2011, 7:23-35. 132. Chan MR, Thomas CP, Torrealba JR, Djamali A, Fernandez LA, Nishimura CJ, Smith RJ, Samaniego MD: Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient. Am J Kidney Dis 2009, 53:321-326. 133. Le Quintrec M, Zuber J, Noel LH, Thervet E, Fr eaux-Bacchi V, Niaudet P, Fridman WH, Legendre C, Dragon-Durey MA: Anti-Factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic 6-(Thiophen-3-yl)pyridin-3-amine and uremic syndrome. Am J Transplant 2009, 9:1223-1229. 6-(Thiophen-3-yl)pyridin-3-amine 134. Waters AM, Pappworth I, Marchbank K, Bockenhauer D, Tullus K, Pickering MC, Strain L, Sebire N, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/13867361 Shroff R, Marks SD, Goodship TH, Rees L: Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T. Am J Transplant 2010, 10:168-172.Loirat and Fr eaux-Bacchi Orphanet Journal of Rare Diseases 2011, 6:60 http://www.ojrd.com/content/6/1/Page 29 of135. Oyen O, Str EH, Midtvedt K, Bentdal O, Hartmann A, Bergan S, Pfeffer P, Brekke IB: Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome. Am J Transplant 2006, 6:412-418. 136. Hirt-Minkowski P, Schaub S, Mayr M, Schifferli JA, Dickenmann M, Fr eaux-Bacchi V, Steiger J: Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option? Nephrol Dial Transplant 2009, 24:3548-3551. 137. Davin JC, Gracchi V, Bouts A, Groothoff J, Strain L, Goodship T: Maintenance of Kidney Function Following Treatment With Eculizumab and Discontinuation of Plasma Exchange After a Third Kidney Transplant for Atypical Hemolytic Uremic Syndrome Associated With a CFH Mutation. Am J Kidney Dis 2010, 55:708-711. 138. Albertazzi V, Bonucchi D, De Amicis S, Americo C, Ghiandai G, Cappelli G: A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report. Transplant Proc 2010, 42:1352-1354. 139. Cruzado JM, de C doba SR, Melilli E, Bestard O,.
A Ciência & Ensino é uma publicação semestral destinada a professores de ciências do ensino fundamental e médio e seus formadores.
Zzi G, Consensus Study Group: Liver-kidney transplantation to cure atypical hemolytic
por Carin Hanton (2024-06-05)
Zzi G, Consensus Study Group: Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J Am Soc Nephrol 2009, 20:940-949. 126. Michon B, Moghrabi A, Winikoff R, Barrette S, Bernstein ML, Champagne J, David M, Duval M, Hume HA, Robitaille N, B isle A, Champagne MA: Complications of apheresis in children. Transfusion 2007, 47:1837-1842. 127. Witt V, Stegmayr B, Ptak J, Wikstr B, Berlin G, Axelsson CG, Griskevicius A, Centoni PE, Liumbruno GM, Molfettini P, Audzijoniene J, Mokvist K, Sojka BN, Norda R, Ramlow W, Blaha M, Evergren M, Tomaz J: World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry. Transfus Apher Sci 2008, 39:255-260. 128. Bresin E, Daina E, Noris M, Castelletti F, Stefanov R, Hill P, Goodship HT, Remuzzi G: Outcome of renal transplantation in patients with Non-ShigaToxin associated hemolytic syndrome: prognostic significance of genetic background. Clin J Am Soc Nephrol 2006, 1:88-99. 129. Loirat PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/23410069 C, Fremeaux-Bacchi V: Hemolytic uremic syndrome recurrence after renal transplantation. Pediatr Transpl 2008, 12:619-629. 130. Noris M, Remuzzi G: Thrombotic microangiopathy after kidney transplantation. Am J Transplant 2010, 10:1517-1523. 131. Zuber J, Le Quintrec M, Sberro-Soussan R, Loirat C, Fr eaux-Bacchi V, Legendre C: New insights into postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol 2011, 7:23-35. 132. Chan MR, Thomas CP, Torrealba JR, Djamali A, Fernandez LA, Nishimura CJ, Smith RJ, Samaniego MD: Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient. Am J Kidney Dis 2009, 53:321-326. 133. Le Quintrec M, Zuber J, Noel LH, Thervet E, Fr eaux-Bacchi V, Niaudet P, Fridman WH, Legendre C, Dragon-Durey MA: Anti-Factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic 6-(Thiophen-3-yl)pyridin-3-amine and uremic syndrome. Am J Transplant 2009, 9:1223-1229. 6-(Thiophen-3-yl)pyridin-3-amine 134. Waters AM, Pappworth I, Marchbank K, Bockenhauer D, Tullus K, Pickering MC, Strain L, Sebire N, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/13867361 Shroff R, Marks SD, Goodship TH, Rees L: Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T. Am J Transplant 2010, 10:168-172.Loirat and Fr eaux-Bacchi Orphanet Journal of Rare Diseases 2011, 6:60 http://www.ojrd.com/content/6/1/Page 29 of135. Oyen O, Str EH, Midtvedt K, Bentdal O, Hartmann A, Bergan S, Pfeffer P, Brekke IB: Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome. Am J Transplant 2006, 6:412-418. 136. Hirt-Minkowski P, Schaub S, Mayr M, Schifferli JA, Dickenmann M, Fr eaux-Bacchi V, Steiger J: Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option? Nephrol Dial Transplant 2009, 24:3548-3551. 137. Davin JC, Gracchi V, Bouts A, Groothoff J, Strain L, Goodship T: Maintenance of Kidney Function Following Treatment With Eculizumab and Discontinuation of Plasma Exchange After a Third Kidney Transplant for Atypical Hemolytic Uremic Syndrome Associated With a CFH Mutation. Am J Kidney Dis 2010, 55:708-711. 138. Albertazzi V, Bonucchi D, De Amicis S, Americo C, Ghiandai G, Cappelli G: A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report. Transplant Proc 2010, 42:1352-1354. 139. Cruzado JM, de C doba SR, Melilli E, Bestard O,.